An ELISA for glial fibrillary acidic protein (original) (raw)
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults
Lars Rosengren
Journal of Neuroscience Methods, 1994
View PDFchevron_right
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Marta Milà Alomà
JAMA Neurology
View PDFchevron_right
Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
Helmuth Steinmetz
PLoS ONE, 2013
View PDFchevron_right
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children
Lars Rosengren
Journal of Neuroscience Methods, 1992
View PDFchevron_right
Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury
carlos barron
Alzheimer's Research & Therapy, 2021
View PDFchevron_right
Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker
Kevin K.W. Wang
Trends in neurosciences, 2015
View PDFchevron_right
Measurement of glial fibrillary acidic protein (GFAP) and anti-GFAP antibodies by solid-phase radioimmunoassays
Juhani Ruutiainen
Acta Neurologica Scandinavica, 2009
View PDFchevron_right
Measurement of glial fibrillary acidic protein by a two-site immunoradiometric assay
Lim Eng
Analytical Biochemistry, 1976
View PDFchevron_right
Glial Fibrillary Acidic Protein Serum Level as a Predictor of Clinical Outcome in Ischemic Stroke
VINSON HARTOYO
Open Access Macedonian Journal of Medical Sciences, 2019
View PDFchevron_right
Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)
Roopa Ghirnikar
Neurochemical Research, 2000
View PDFchevron_right
Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
Isabel Sala
Translational Neurodegeneration, 2021
View PDFchevron_right
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Johannes Levin
Journal of Neurology, Neurosurgery & Psychiatry
View PDFchevron_right
Role of glial fibrillary acidic protein (GFAP) marker in central nervous system lesions
IP Innovative Publication Pvt. Ltd.
IP Innovative Publication Pvt. Ltd., 2017
View PDFchevron_right
Serum Glial Fibrillary Acidic Protein Levels Profile in Patients with Severe Traumatic Brain Injury
Arief Hariyanto
Indonesian Journal of Clinical Pathology and Medical Laboratory, 2018
View PDFchevron_right
Specific Human Astrocyte Subtype Revealed by Affinity Purified GFAP+1 Antibody; Unpurified Serum Cross-Reacts with Neurofilament-L in Alzheimer
Jaap Middeldorp
PLoS ONE, 2009
View PDFchevron_right
Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system
Milos Pekny
Current Opinion in Cell Biology, 2015
View PDFchevron_right
Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage
Ioannis Rizos
Stroke, 2017
View PDFchevron_right
Identification of a human glial fibrillary acidic protein cDNA: A tool for the molecular analysis of reactive gliosis in the mammalian central nervous system
Nicole Biguet
Journal of Neuroscience Research, 1988
View PDFchevron_right
Serum Glial Fibrillary Acidic Protein Is Related to Focal Brain Injury and Outcome After Aneurysmal Subarachnoid Hemorrhage
Lars Rosengren
Stroke, 2007
View PDFchevron_right
Quantification of neurodegeneration by measurement of brain-specific proteins
Gavin Giovannoni
Journal of Neuroimmunology, 2003
View PDFchevron_right
Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas
Lars Rosengren
Acta Neurologica Scandinavica, 2007
View PDFchevron_right
The Influence of Sampling Time to Serum Glial Fibrillary Acidic Protein (Gfap) Levels in Acute Stroke
neila raisa
MNJ (Malang Neurology Journal)
View PDFchevron_right
Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
Ann Dring
PLOS ONE, 2015
View PDFchevron_right
Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
Akshatha Ganne
Pharmaceutics
View PDFchevron_right
Glial fibrillary acidic protein as a biomarker for periventricular white matter injury
Frances Northington
American Journal of Obstetrics and Gynecology, 2013
View PDFchevron_right
Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke
Sven Klimpe
Clinical Chemistry, 2012
View PDFchevron_right
Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain
Tuula Nyman
Neurobiology of …, 2005
View PDFchevron_right
Recent Studies of the Glial Fibrillary Acidic Proteina
Marion smith
Annals of the New York Academy of Sciences, 1985
View PDFchevron_right
Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type
M. Tardy
Neuroscience Letters, 1993
View PDFchevron_right
Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
Michel Freriks, Jinte Middeldorp
2014
View PDFchevron_right
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Hayrettin Tumani
Nature Reviews Neurology, 2022
View PDFchevron_right